University Hospital Carl Gustav Carus Dresden

As one of the leading university hospitals in Germany, the University Hospital Carl Gustav Carus Dresden offers its patients state-of-the-art health care and covers nearly the whole range of maximum care. Its focus lies on cancer therapy, metabolic and neurological diseases. In 2015 the hospital treated 57.451 inpatient cases and 272.745 outpatient cases. The foundation of this work efficiency are 5.644 employees and 1.295 hospital beds.
Making progress in the battle against cancer cannot be achieved without interdisciplinary exchange. That is why the University Hospital Carl Gustav Carus Dresden, the Helmholtz-Zentrum Dresden-Rossendorf and the Carl Gustav Carus Faculty of Medicine at TU Dresden have joined forces at the OncoRay Center. Its focus lies on translational research, which means bringing results from the laboratory to the patients as fast as possible. Therefore scientists at OncoRay verify promising research results together with physicians at the Department of Radiation Oncology of the university hospital in various clinical studies. Often other national and international departments, research groups and industrial partners are involved.

Radiation therapy with protons

Since 2014 cancer patients can be treated at the University Proton Therapy Dresden (UPTD) with the innovative method of proton therapy. In addition to serving patients, the facility is also made available to scientists to do research and improve the use of protons in cancer therapy.

Other research cooperations

Together with the German Cancer Research Center (DKFZ), the Carl Gustav Carus Faculty of Medicine at TU Dresden and the Helmholtz-Zentrum Dresden-Rossendorf the university hospital has established the NCT Dresden in 2015. Thereby it is reinforcing its overall outstanding position in innovative therapy and patient-centered research. The University Hospital Dresden is well renowned far beyond Germany. Together with the institutions mentioned above and other partners it is also a part of the German Cancer Consortium (DKTK).